Author:
Suzuki Takako,Sato Yoshitaka,Okuno Yusuke,Torii Yuka,Fukuda Yuto,Haruta Kazunori,Yamaguchi Makoto,Kawamura Yoshiki,Hama Asahito,Narita Atsushi,Muramatsu Hideki,Yoshikawa Tetsushi,Takahashi Yoshiyuki,Kimura Hiroshi,Ito Yoshinori,Kawada Jun-ichi
Funder
Japan Society for the Promotion of Science
JST PRESTO
JST CREST
Mitsubishi Foundation Research Grant 2020
Masato Kawano Memorial Public Interest Foundation for Promotion of Pediatrics
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Sumaya CV, Ench Y. Epstein-Barr virus infectious Mononucleosis in children. I. Clinical and general laboratory findings. Pediatrics. 1985;75:1003–10.
2. Henter J-I, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.
3. Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58–65.
4. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol/Hematol. 2002;44:283–94.
5. Zhang K, Wakefield E, Marsh R et al. Lymphoproliferative disease, X-Linked. In: Adam MP MG, Pagon RA, editor. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023; 2004 Feb 27 [Updated 2016 Jun 30].